In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...

Newly listed nerve-repair company ReNerve has inked an exclusive distribution partnership with Accession Medical Supplies for the sales and marketing ... Read More The post ReNerve inks deal to expand ...

NASHVILLE, Tenn. ( WSMV /Gray News) - For the first time in more than a hundred years, there’s now an FDA-approved ...

As e-cigarettes have flooded the market, the FDA's role in approving new tobacco products is put under a microscope.

During a hearing Monday, the Supreme Court didn't seem convinced the FDA was unfair in blocking flavored vapes as teen use ...

Adaptimmune is a fully integrated cell therapy company working to redefine how cancer is treated. With its unique engineered ...

Applied Therapeutics said on Monday it received a warning letter limited to a trial studying its genetic disease drug, after ...

This parasiticide product was previously approved for killing adult fleas ( Ctenocephalides felis ), treating and preventing ...

In the ongoing case, vaping companies argue that the FDA was “arbitrary and capricious” in rejecting applications for ...

The Food and Drug Administration (FDA) has approved Yesintek TM (ustekinumab-kfce), a biosimilar to Stelara ® (Ustekinumab), for the treatment of various chronic inflammatory diseases. Yesintek, ...

Yesintek is the latest Stelara biosimilar to gain FDA approval and it will be available in February 2025.

The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Applied Therapeutics regarding the New Drug Application (NDA) for govorestat for the treatment of classic ...